Controlled formation of metallic tellurium nanocrystals in tellurite glasses using femtosecond direct laser writing

Tellurite glasses are considered a potential alternative for applications not achieved by SiO2-based glasses, presenting interesting optical properties, such as high linear and nonlinear refractive indexes, extended optical window, being also suitable for metallic nanoparticle growth, like Te0. When doped with sulfide species, it can benefit the reduction of Te4+ to Te0, which can be advantageous to synthesize in-situ chalcogenide nanoparticles and quantum dots. This work presents investigations on the reduction of Te4+ to Te0 in tellurite glasses doped with PbS and PbO/ZnS, and aims to control this redox process through the processing with pulsed fs-laser. Tellurite glass samples were synthesized by melt-quenching technique and the thermal and structural properties were explored by different techniques, such as DSC, Raman scattering spectroscopy and mapping experiment, TEM and SAED. Reduction of tellurium to Te0 nanocrystals into tellurite glass after laser irradiation was studied in detail and confirmed by the presence of bands at ~120 and 140 cm−1 in Raman spectroscopy and mapping, assigned to the Te–Te vibrational modes, which suggest that S2− induces in-situ Te4+ reduction. Moreover, quasi spherical tellurium nanoparticles were observed through TEM and confirmed their chemical nature and crystallization by SAED. The study of tellurium reduction in the vitreous matrix becomes particularly important and promising for some applications, since its reduction generates changes in the refractive index by precipitation of Te0 nanoparticles, allowing the fabrication of waveguides and as photosensitive material for tridimensional data storage

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

BackgroundWe previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15-20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in similar to 80% of cases.MethodsWe report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded.ResultsNo gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5-528.7, P=1.1x10(-4)) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR=3.70[95%CI 1.3-8.2], P=2.1x10(-4)). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR=19.65[95%CI 2.1-2635.4], P=3.4x10(-3)), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR=4.40[9%CI 2.3-8.4], P=7.7x10(-8)). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD]=43.3 [20.3] years) than the other patients (56.0 [17.3] years; P=1.68x10(-5)).ConclusionsRare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old